Bioabsorbable Stents Market Analysis, Top Companies, New Technology, Demand and Opportunity Analysis
The
increasing incidences of cardiovascular diseases (CVDs) and increasing number
of obese people worldwide are some of the major growth drivers for the global bioabsorbable stents market. CVDs are characterized by disorders
of the heart and blood vessels. The major disorders include cerebrovascular
disease, coronary heart disease, and rheumatic heart disease. People at risk of
CVDs are affected with increased blood pressure, as well as obesity. According
to the World Health Organization (WHO), 17.5 million people die from CVDs every
year around the world.
The
stringent government regulations for the approval of bioabsorbable stent, and
high risk of side-effects associated with the implantation of stents in the
body are some of the common factors, restraining the growth of the global
bioabsorbable stents market. Moreover, the lack of awareness towards innovative
and interventional applications of bioabsorbable stents, and lack of
reimbursement policies are also hindering the growth of the bioabsorbable
stents market, especially in the developing countries. However countries, such
as India and China are expected to witness a considerable growth during the
forecast period, owing to increasing aging population and growing incidences of
CVDs.
Download
Free Sample of This Research Report :
In Europe,
Germany, the U.K., France, and Italy are some of the major countries, holding
significant share of the bioabsorbable stents market of the region. In North
America, the U.S, followed by Canada, is the largest market for bioabsorbable
stents. In Asia-Pacific, India, Japan, and China are the major markets for
bioabsorbable stents. The Asia-Pacific bioabsorbable stents market is expected
to witness fastest growth, attributed to the increasing healthcare expenditure
and presence of large pool of patients.
Some of the
major players operating in global bioabsorbable stents market include, Zorion
Medical, Tepha, S3V Vascular Technologies, REVA Medical, Medlogics Device
Corporation, Kyoto Medical Planning, ICON Interventional Systems, Elixir
Medical Corporation, Biotronik, Arterial Remodelling Technologies Arterius,
Amaranth Medical, and Abbott Vascular.
Comments
Post a Comment